CN108524896A - 一种治疗精神抑郁症的中药及其制备方法 - Google Patents
一种治疗精神抑郁症的中药及其制备方法 Download PDFInfo
- Publication number
- CN108524896A CN108524896A CN201810710227.3A CN201810710227A CN108524896A CN 108524896 A CN108524896 A CN 108524896A CN 201810710227 A CN201810710227 A CN 201810710227A CN 108524896 A CN108524896 A CN 108524896A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cyclodextrin
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 29
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 29
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 29
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 29
- 229960004853 betadex Drugs 0.000 claims abstract description 29
- 235000019082 Osmanthus Nutrition 0.000 claims abstract description 19
- 241000333181 Osmanthus Species 0.000 claims abstract description 19
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 18
- 239000003765 sweetening agent Substances 0.000 claims abstract description 18
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 16
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 16
- 239000007884 disintegrant Substances 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 244000205574 Acorus calamus Species 0.000 claims abstract description 14
- 235000011996 Calamus deerratus Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 239000010502 orange oil Substances 0.000 claims abstract description 14
- 241001522129 Pinellia Species 0.000 claims abstract description 13
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 13
- 235000008397 ginger Nutrition 0.000 claims abstract description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 12
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 12
- 239000000853 adhesive Substances 0.000 claims abstract description 11
- 230000001070 adhesive effect Effects 0.000 claims abstract description 11
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000661 sodium alginate Substances 0.000 claims abstract description 10
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 10
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 10
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 7
- 239000008187 granular material Substances 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 235000019441 ethanol Nutrition 0.000 claims description 36
- 239000000284 extract Substances 0.000 claims description 25
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 18
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 18
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 18
- 241000208340 Araliaceae Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000006286 aqueous extract Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 238000001256 steam distillation Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- -1 hydroxyl Propyl Chemical group 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 11
- 235000014347 soups Nutrition 0.000 abstract description 7
- 229940126678 chinese medicines Drugs 0.000 abstract description 3
- 230000001965 increasing effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 12
- 241000234314 Zingiber Species 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 241001247821 Ziziphus Species 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 3
- 208000020401 Depressive disease Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000007415 Anhedonia Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010050013 Abulia Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 1
- 201000009916 Postpartum depression Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 239000008563 guizhi decoction Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000008767 xiaochaihu Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗精神抑郁症的中药及其制备方法,所述的中药为颗粒剂,按照重量份计,包括柴胡10份、黄芩10份、桂支10份、赤白芍10份、半夏10份、生姜10份、陈皮10份、枳壳10份、竹茹10份、远志10份、茯苓20份、人参5份、菖蒲6份、大枣6份、灸甘草6份、香附3‑5份、神曲3‑5份、五味子6‑8份、甜橙精油1‑2份,β‑环糊精70‑80、崩解剂3‑5份、甜味剂3‑5份、粘合剂3‑5份、海藻酸钠2‑3份。本发明的治疗精神抑郁症的中药,相比柴桂温胆定志汤,通过增加药物,采用特殊的制备方法,有效的提高了治疗效果。
Description
技术领域
本发明涉及一种治疗精神抑郁症的中药及其制备方法,属于中药技术领域。
背景技术
抑郁症是以情绪低落、兴趣缺失、快感缺乏等一系列负向情绪为临床症状的一类复杂性疾病。其病因复杂,涉及遗传、环境、社会心理等多方面的因素。抑郁症具有发病率高,治愈性低的特点,给患者及社会,带来严重的经济负担与压力。目前,抑郁症的临床用药主要有三环类药物,五经色胺再摄取抑制剂,单胺氧化酶抑制剂等。因为临床病人病因及病情状态的复杂性,西药制剂在临床的应用,存在着用药反应不一,不良反应大、价格昂贵的缺点。中医在治疗抑郁症的辨证方面可分为辨脑神、心神与五脏神病,辨脏腑辨虚实、辨六郁。总的治疗原则是攻补兼施、理气开郁、怡情易性若是实证,先理气开郁,而有血、痰、火、湿、食者应分别采用活血、化痰、降火、祛湿、消食等法。虚证应据其所损脏腑及气血阴阳亏虚的不同而补之。可用养心安神、补肾益脑、调理脾胃、滋养肝肾等法。虚实兼杂者则视何者偏重而虚实兼顾。柴桂温胆定志汤由柴胡、黄芩、桂枝、赤白芍、半夏、生姜、陈皮、茯苓、人参、菖蒲、远志、枳壳、竹茹、大枣、炙甘草等药组成。即由柴胡桂枝汤、温胆汤、定志小丸、四逆散等合方化裁。方中人参补五脏、益元气、安精神、定魂魄、开心健脑。茯苓利窍去湿导浊,补心益脑醒神。菖蒲、远志豁痰开窍振心阳、益智慧、醒脑神。小柴胡汤疏达郁结、振奋肝胆脾胃;桂枝汤取桂枝、甘草等辛甘化阳以温补心阳;温胆汤以增强涤痰醒神定志之力。诸方相合,寒温并用,攻补同施,共奏温补心阳、疏解肝郁、豁痰开窍、养脑醒神之效。柴桂温胆定志方有良好的疗效,无任何毒副作用,并且克服了西药的不足和局限性,具有疗效好、无副作用的优点。但是柴桂温胆定志汤的治疗效果并不是很好,有效率在80%左右。
发明内容
本发明提供了一种治疗精神抑郁症的中药及其制备方法,解决了现有治疗抑郁的中药效果不好以及药物利用度低等问题。
为解决上述技术问题,本发明采用的技术方案为:
一种治疗精神抑郁症的中药,所述的中药为颗粒剂,按照重量份计,包括柴胡10份、黄芩10份、桂支10份、赤白芍10份、半夏10份、生姜10份、陈皮10份、枳壳10份、竹茹10份、远志10份、茯苓20份、人参5份、菖蒲6份、大枣6份、灸甘草6份、香附3-5份、神曲3-5份、五味子6-8份、甜橙精油1-2份,β-环糊精70-80份、崩解剂3-5份、甜味剂3-5份、粘合剂3-5份、海藻酸钠2-3份。
进一步,本发明的一种优选方案为:所述的崩解剂为羧甲基淀粉钠或低取代羟丙甲纤维素。
进一步,本发明的一种优选方案为:所述的粘合剂为羟丙基纤维素。
进一步,本发明的一种优选方案为:所述的甜味剂为所述的甜味剂可以为甜菊糖、麦芽糖醇、山梨醇、、果糖中一种或两种以上。
本发明的治疗精神抑郁症的中药的制备方法,包括以下步骤:
(1)将柴胡、黄芩、桂支、赤白芍、半夏、生姜、陈皮、枳壳、竹茹、远志、茯苓、菖蒲、大枣、灸甘草、香附和五味子粉碎,按照1g:10ml加水,然后水蒸气蒸馏3-4h,得馏分、水提液和药渣,药渣按照1g:5l的比例加60%乙醇,30-40度,提取2-3h,过滤,得到醇提液,将醇提液和水提液合并,除去乙醇,并浓缩至相对密度为1.30-1.35的浸膏;
(2)将人参和神曲粉碎,备用;
(3)将60%的β-环糊精加入真空设备,然后将甜橙精油和步骤一的馏分混合均匀,然后加入到β-环糊精中,真空处理10-20min,然后加入海藻酸钠混合均匀;
(4)将20%的β-环糊精和浸膏混合均匀,备用;
(5)将羟丙基纤维素溶于95%的乙醇中,制得10%羟丙基纤维素乙醇溶液,
(6)步骤2、3和4所得的产物、剩余β-环糊精、崩解剂和甜味剂混合均匀,然后利用10%羟丙基纤维素乙醇溶液制粒;
(7)将步骤6的制得的湿粒干燥后即得。
本发明的有益效果:
本发明在柴桂温胆定志汤的基础上,通过研究,添加香附、神曲、五味子和甜橙精油,香附具有疏肝解郁,理气宽中,用于肝郁气滞,胸胁胀痛,脾胃气滞,脘腹痞闷,胀满疼痛。神曲为面粉和其他药物混合后经发酵而成的加工品。具有消食和胃的功效。主治饮食积滞。添加神曲可以有效的增加患者的食欲,改善肠胃功能,有效提高药物的吸收利用。五味子具有收敛固涩,益气生津,补肾宁心的功效,对神经系统各级中枢均有兴奋作用,对大脑皮质的兴奋和抑制过程均有影响,使之趋于平衡。对呼吸系统有兴奋作用,有镇咳和祛痰作用。能降低血压。能利胆,降低血清转氨酶,对肝细胞有保护作用。有与人参相似的适应原样作用,能增强机体对非特异性刺激的防御能力。能增加细胞免疫功能,使脑、肝、脾脏SOD活性明显增强,故具有提高免疫、抗氧化、抗衰老作用。对金黄色葡萄球菌、肺炎杆菌、肠道沙门菌、绿脓杆菌等均有抑制作用。甜橙精油是少数有镇静作用的精油之一,有着甜甜橙香味的甜橙精油,可以驱离紧张情绪和压力、改善焦虑所引起的失眠,由于橙皮中含有大量的维他命C,能预防感冒、对皮肤有保湿效果、能平衡皮肤的酸咸值、帮助胶原形成,对于身体组织的生长与修复有良好的功效。能促进发汗,因而可帮助阻塞的皮肤排出毒素,对油性、暗疮或乾燥皮肤者皆有帮助。添加具有治疗抑郁,提高兴奋度的香附五味子和甜橙精油,可以有效的提高柴桂温胆定志汤的疗效。
治疗抑郁的药物中大部分是挥发油在其作用,而传统的制剂方法为煎煮,会导致其有效成分流失,降低药效。本发明通过特殊的工艺,首先通过三种提取工艺,将挥发油、水溶成分和醇溶成分充分提取出来,有效的提高了有效成分的提取利用率,然后不同成分采用不同方法,挥发油采用真空处理,使得挥发油充分进入到β-环糊精,然后在于β-环糊精复合使挥发油被包裹在β-环糊精内部,有效的避免了挥发油的流失。采用本发明的方法,可以有效的提高药物的利用率,提高疗效。
具体实施方式
下面将结合本发明实施例,对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种治疗精神抑郁症的中药,所述的中药为颗粒剂,按照重量份计,包括柴胡10份、黄芩10份、桂支10份、赤白芍10份、半夏10份、生姜10份、陈皮10份、枳壳10份、竹茹10份、远志10份、茯苓20份、人参5份、菖蒲6份、大枣6份、灸甘草6份、香附3份、神曲5份、五味子6份、甜橙精油2份,β-环糊精70份、崩解剂3份、甜味剂5份、粘合剂3份、海藻酸钠3份。
崩解剂为羧甲基淀粉钠。
粘合剂为羟丙基纤维素。
所述的甜味剂为甜菊糖。
其制备方法,包括以下步骤:
(1)将柴胡、黄芩、桂支、赤白芍、半夏、生姜、陈皮、枳壳、竹茹、远志、茯苓、菖蒲、大枣、灸甘草、香附和五味子粉碎,按照1g:10ml加水,然后水蒸气蒸馏3h,得馏分、水提液和药渣,药渣按照1g:5l的比例加60%乙醇,30-40度,提取2h,过滤,得到醇提液,将醇提液和水提液合并,除去乙醇,并浓缩至相对密度为1.30-1.35的浸膏;
(2)将人参和神曲粉碎,备用;
(3)将60%的β-环糊精加入真空设备,然后将甜橙精油和步骤一的馏分混合均匀,然后加入到β-环糊精中,真空处理10min,然后加入海藻酸钠混合均匀;
(4)将20%的β-环糊精和浸膏混合均匀,备用;
(5)将羟丙基纤维素溶于95%的乙醇中,制得10%羟丙基纤维素乙醇溶液,
(6)步骤2、3和4所得的产物、剩余β-环糊精、崩解剂和甜味剂混合均匀,然后利用10%羟丙基纤维素乙醇溶液制粒;
(7)将步骤6的制得的湿粒干燥后即得。
实施例2
一种治疗精神抑郁症的中药,所述的中药为颗粒剂,按照重量份计,包括柴胡10份、黄芩10份、桂支10份、赤白芍10份、半夏10份、生姜10份、陈皮10份、枳壳10份、竹茹10份、远志10份、茯苓20份、人参5份、菖蒲6份、大枣6份、灸甘草6份、香附4份、神曲4份、五味子7份、甜橙精油1份,β-环糊精75份、崩解剂4份、甜味剂4份、粘合剂4份、海藻酸钠3份。
崩解剂为低取代羟丙甲纤维素。
粘合剂为羟丙基纤维素。
所述的甜味剂为麦芽糖醇。
其制备方法,包括以下步骤:
(1)将柴胡、黄芩、桂支、赤白芍、半夏、生姜、陈皮、枳壳、竹茹、远志、茯苓、菖蒲、大枣、灸甘草、香附和五味子粉碎,按照1g:10ml加水,然后水蒸气蒸馏4h,得馏分、水提液和药渣,药渣按照1g:5l的比例加60%乙醇,30-40度,提取3h,过滤,得到醇提液,将醇提液和水提液合并,除去乙醇,并浓缩至相对密度为1.30-1.35的浸膏;
(2)将人参和神曲粉碎,备用;
(3)将60%的β-环糊精加入真空设备,然后将甜橙精油和步骤一的馏分混合均匀,然后加入到β-环糊精中,真空处理20min,然后加入海藻酸钠混合均匀;
(4)将20%的β-环糊精和浸膏混合均匀,备用;
(5)将羟丙基纤维素溶于95%的乙醇中,制得10%羟丙基纤维素乙醇溶液,
(6)步骤2、3和4所得的产物、剩余β-环糊精、崩解剂和甜味剂混合均匀,然后利用10%羟丙基纤维素乙醇溶液制粒;
(7)将步骤6的制得的湿粒干燥后即得。
实施例3
一种治疗精神抑郁症的中药,所述的中药为颗粒剂,按照重量份计,包括柴胡10份、黄芩10份、桂支10份、赤白芍10份、半夏10份、生姜10份、陈皮10份、枳壳10份、竹茹10份、远志10份、茯苓20份、人参5份、菖蒲6份、大枣6份、灸甘草6份、香附5份、神曲3份、五味子8份、甜橙精油1份,β-环糊精80份、崩解剂5份、甜味剂3份、粘合剂5份、海藻酸钠2份。
崩解剂为羧甲基淀粉钠。
粘合剂为羟丙基纤维素。
所述的甜味剂为果糖。
其制备方法,包括以下步骤:
(1)将柴胡、黄芩、桂支、赤白芍、半夏、生姜、陈皮、枳壳、竹茹、远志、茯苓、菖蒲、大枣、灸甘草、香附和五味子粉碎,按照1g:10ml加水,然后水蒸气蒸馏3h,得馏分、水提液和药渣,药渣按照1g:5l的比例加60%乙醇,30-40度,提取3h,过滤,得到醇提液,将醇提液和水提液合并,除去乙醇,并浓缩至相对密度为1.30-1.35的浸膏;
(2)将人参和神曲粉碎,备用;
(3)将60%的β-环糊精加入真空设备,然后将甜橙精油和步骤一的馏分混合均匀,然后加入到β-环糊精中,真空处理20min,然后加入海藻酸钠混合均匀;
(4)将20%的β-环糊精和浸膏混合均匀,备用;
(5)将羟丙基纤维素溶于95%的乙醇中,制得10%羟丙基纤维素乙醇溶液,
(6)步骤2、3和4所得的产物、剩余β-环糊精、崩解剂和甜味剂混合均匀,然后利用10%羟丙基纤维素乙醇溶液制粒;
(7)将步骤6的制得的湿粒干燥后即得。
疗效实验:
选取某医院换精神抑郁的患者120名,男68名,女52名,年龄在18-65岁,随机分为4组,每组30人。
抑郁症的诊断标准:抑郁症诊断参照《中国精神疾病分类与诊断标准·第3版》(CCMD-3)的诊断标准。
抑郁症肝肾阳虚型的中医辨证标准:参照《抑郁症肝肾阳虚证的宏观辨证指标研究》中的辨证指标。主症:情绪低沉、神疲乏力、兴趣减退、性欲减退、畏寒喜暖;次症:善惊易恐、腰膝酸软、意志减退、思维迟缓、少言寡语、舌体胖大、舌质淡暗(白)。如果患者同时具备主症中的症状至少4项,次症中的症状至少6项,且症状持续至少2周,即可诊为抑郁症肝‘肾阳虚型。
纳入标准:符合抑郁症诊断标准中的轻、中度患者;符合抑郁症肝肾阳虚型中医辨证标准患者;年龄18-65岁;生命体征平稳,神志清楚,有一定表达能力;签订知情同意书,同意参加本次研究。同时符合上述6项方可入选。
排除标准:经前或经后抑郁症、产前或产后抑郁症、减肥后抑郁症、滥用药物后抑郁症的患者。
治疗方法:
1-3组服用本发明的实施例1-3所制备的治疗精神抑郁的颗粒剂,每天早中晚三次,每次10g,开水冲服。一个疗程为4周,服用3个疗程
4组采用柴桂温胆定志汤(柴胡、黄芩、桂枝、赤白芍、半夏、生姜、陈皮、枳壳、竹茹各10g,茯苓20g,人参5g,菖蒲6g,远志10g,大枣5枚,炙甘草6g)水煎口服,每日1剂,饭后分3次服用。一个疗程为4周,服用3个疗程
评定标准:
治愈:精神症状全部消失,接触良好,能参加社会活动,自知力恢复;
有效:精神症状大部分恢复,能参加部分社会活动,自知力大部分恢复;
无效:精神症状没有改善,甚至加重。
其中总有效率=(治愈+有效)/总例数*100%。
由上表可知,本发明的治疗精神抑郁症的中药,相比柴桂温胆定志汤,通过增加药物,采用特殊的制备方法,有效的提高了治疗效果。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (5)
1.一种治疗精神抑郁症的中药,其特征在于:所述的中药为颗粒剂,按照重量份计,包括柴胡10份、黄芩10份、桂支10份、赤白芍10份、半夏10份、生姜10份、陈皮10份、枳壳10份、竹茹10份、远志10份、茯苓20份、人参5份、菖蒲6份、大枣6份、灸甘草6份、香附3-5份、神曲3-5份、五味子6-8份、甜橙精油1-2份,β-环糊精70-80份、崩解剂3-5份、甜味剂3-5份、粘合剂3-5份、海藻酸钠2-3份。
2.根据权利要求1所述的一种治疗精神抑郁症的中药,其特征在于:所述的崩解剂为羧甲基淀粉钠或低取代羟丙甲纤维素。
3.根据权利要求1所述的一种治疗精神抑郁症的中药,其特征在于:所述的粘合剂为羟丙基纤维素。
4.根据权利要求1所述的一种治疗精神抑郁症的中药,其特征在于:所述的甜味剂为所述的甜味剂可以为甜菊糖、麦芽糖醇、山梨醇、、果糖中一种或两种以上。
5.一种如权利要求3所述的一种治疗精神抑郁症的中药的制备方法,其特征在于,包括以下步骤:
(1)将柴胡、黄芩、桂支、赤白芍、半夏、生姜、陈皮、枳壳、竹茹、远志、茯苓、菖蒲、大枣、灸甘草、香附、和五味子粉碎,按照1g:10ml加水,然后水蒸气蒸馏3-4h,得馏分、水提液和药渣,药渣按照1g:5l的比例加60%乙醇,30-40度,提取2-3h,过滤,得到醇提液,将醇提液和水提液合并,除去乙醇,并浓缩至相对密度为1.30-1.35的浸膏;
(2)将人参和神曲粉碎,备用;
(3)将60%的β-环糊精加入真空设备,然后将甜橙精油和步骤一的馏分混合均匀,然后加入到β-环糊精中,真空处理10-20min,然后加入海藻酸钠混合均匀;
(4)将20%的β-环糊精和浸膏混合均匀,备用;
(5)将羟丙基纤维素溶于95%的乙醇中,制得10%羟丙基纤维素乙醇溶液,
(6)步骤2、3和4所得的产物、剩余β-环糊精、崩解剂和甜味剂混合均匀,然后利用10%羟丙基纤维素乙醇溶液制粒;
(7)将步骤6的制得的湿粒干燥后即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810710227.3A CN108524896A (zh) | 2018-07-02 | 2018-07-02 | 一种治疗精神抑郁症的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810710227.3A CN108524896A (zh) | 2018-07-02 | 2018-07-02 | 一种治疗精神抑郁症的中药及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108524896A true CN108524896A (zh) | 2018-09-14 |
Family
ID=63487654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810710227.3A Withdrawn CN108524896A (zh) | 2018-07-02 | 2018-07-02 | 一种治疗精神抑郁症的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108524896A (zh) |
-
2018
- 2018-07-02 CN CN201810710227.3A patent/CN108524896A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN102078520A (zh) | 一种治疗神经性头痛的中药制剂及其制备方法 | |
CN103719492B (zh) | 一种绞股蓝护肝养肝保健茶及其制备方法 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN105311581A (zh) | 一种预防和治疗乳腺增生的中药组合物及其制备方法 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN105497261A (zh) | 一种外用贴剂基质及该基质制成的外用贴剂和助眠贴 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN103877486A (zh) | 用于促升放化疗后白细胞数量的药物及其制备方法 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN104524174A (zh) | 一种治疗风湿痹痛的中药组合物及其制备方法 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN104587299A (zh) | 一种治疗胃及十二指肠溃疡的中药制剂 | |
CN105079451B (zh) | 一种蓝莓降糖茶及其制备方法 | |
CN103749820A (zh) | 一种清肝明目的炒青葙子茶及其制备方法 | |
CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
CN105494780A (zh) | 一种护肝降脂的山楂叶保健茶及其制备方法 | |
CN108524896A (zh) | 一种治疗精神抑郁症的中药及其制备方法 | |
CN108853340A (zh) | 一种滋养肝肾的中药及其制备方法 | |
CN103638336A (zh) | 全天麻片 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180914 |